Cargando…

Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases

OBJECTIVES: This study aims to: (i) evaluate the outcome of patients with Harrington class III lesions who were treated according to Harrington classification; (ii) propose a modified surgical classification for Harrington class III lesions; and (iii) assess the efficiency of the proposed modified c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ran, Lim, Chiao Yee, Yang, Yi, Tang, Xiao‐dong, Yan, Tai‐qiang, Yang, Rong‐li, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957435/
https://www.ncbi.nlm.nih.gov/pubmed/33665985
http://dx.doi.org/10.1111/os.12918
_version_ 1783664648639217664
author Wei, Ran
Lim, Chiao Yee
Yang, Yi
Tang, Xiao‐dong
Yan, Tai‐qiang
Yang, Rong‐li
Guo, Wei
author_facet Wei, Ran
Lim, Chiao Yee
Yang, Yi
Tang, Xiao‐dong
Yan, Tai‐qiang
Yang, Rong‐li
Guo, Wei
author_sort Wei, Ran
collection PubMed
description OBJECTIVES: This study aims to: (i) evaluate the outcome of patients with Harrington class III lesions who were treated according to Harrington classification; (ii) propose a modified surgical classification for Harrington class III lesions; and (iii) assess the efficiency of the proposed modified classification. METHODS: This study composes two phases. During phase 1 (2006 to 2011), the clinical data of 16 patients with Harrington class III lesions who were treated by intralesional excision followed by reconstruction of antegrade/retrograde Steinmann pins/screws with cemented total hip arthroplasty (Harrington/modified Harrington procedure) were retrospectively reviewed and further analyzed synthetically to design a modified surgical classification system. In phase 2 (2013 to 2019), 62 patients with Harrington class III lesions were classified and surgically treated according to our modified classification. Functional outcome was assessed using the Musculoskeletal Tumor Society (MSTS) 93 scoring system. The outcome of local control was described using 2‐year recurrence‐free survival (RFS). Owing to the limited sample size, we considered P < 0.1 as significant. RESULTS: In phase 1, the mean surgical time was 273.1 (180 to 390) min and the mean intraoperative hemorrhage was 2425.0 (400.0 to 8000.0) mL, respectively. The mean follow‐up time was 18.5 (2 to 54) months. Recurrence was found in 4 patients and the 2‐year RFS rate was 62.4% (95% confidence interval [CI] 31.6% to 93.2%). The mean postoperative MSTS93 score was 56.5% (20% to 90%). Based on the periacetabular bone destruction, we categorized the lesions into two subgroups: with the bone destruction distal to or around the inferior border of the sacroiliac joint (IIIa) and the bone destruction extended proximal to inferior border of the sacroiliac joint (IIIb). Six patients with IIIb lesions had significant prolonged surgical time (313.3 vs 249.0 min, P = 0.022), massive intraoperative hemorrhage (3533.3 vs 1760.0 mL, P = 0.093), poor functional outcome (46.7% vs 62.3%, P = 0.093), and unfavorable local control (31.3% vs 80.0%, P = 0.037) compared to the 10 patients with IIIa lesions. We then modified the surgical strategy for two subgroup of class III lesions: Harrington/modified Harrington procedure for IIIa lesions and en bloc resection followed by modular hemipelvic endoprosthesis replacement for IIIb lesions. Using the proposed modified surgical classification, 62 patients in the phase 2 study demonstrated improved surgical time (245.3 min, P = 0.086), intraoperative hemorrhage (1466.0 mL, P = 0.092), postoperative MSTS 93 scores (65.3%, P = 0.067), and 2‐year RFS rate (91.3%, P = 0.002) during a mean follow‐up time of 19.9 (1 to 60) months compared to those in the phase 1 study. CONCLUSION: The Harrington surgical classification is insufficient for class III lesions. We proposed modification of the classification for Harrington class III lesions by adding two subgroups and corresponding surgical strategies according to the involvement of bone destruction. Our proposed modified classification showed significant improvement in functional outcome and local control, along with acceptable surgical complexity in surgical management for Harrington class III lesions.
format Online
Article
Text
id pubmed-7957435
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-79574352021-03-19 Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases Wei, Ran Lim, Chiao Yee Yang, Yi Tang, Xiao‐dong Yan, Tai‐qiang Yang, Rong‐li Guo, Wei Orthop Surg Clinical Articles OBJECTIVES: This study aims to: (i) evaluate the outcome of patients with Harrington class III lesions who were treated according to Harrington classification; (ii) propose a modified surgical classification for Harrington class III lesions; and (iii) assess the efficiency of the proposed modified classification. METHODS: This study composes two phases. During phase 1 (2006 to 2011), the clinical data of 16 patients with Harrington class III lesions who were treated by intralesional excision followed by reconstruction of antegrade/retrograde Steinmann pins/screws with cemented total hip arthroplasty (Harrington/modified Harrington procedure) were retrospectively reviewed and further analyzed synthetically to design a modified surgical classification system. In phase 2 (2013 to 2019), 62 patients with Harrington class III lesions were classified and surgically treated according to our modified classification. Functional outcome was assessed using the Musculoskeletal Tumor Society (MSTS) 93 scoring system. The outcome of local control was described using 2‐year recurrence‐free survival (RFS). Owing to the limited sample size, we considered P < 0.1 as significant. RESULTS: In phase 1, the mean surgical time was 273.1 (180 to 390) min and the mean intraoperative hemorrhage was 2425.0 (400.0 to 8000.0) mL, respectively. The mean follow‐up time was 18.5 (2 to 54) months. Recurrence was found in 4 patients and the 2‐year RFS rate was 62.4% (95% confidence interval [CI] 31.6% to 93.2%). The mean postoperative MSTS93 score was 56.5% (20% to 90%). Based on the periacetabular bone destruction, we categorized the lesions into two subgroups: with the bone destruction distal to or around the inferior border of the sacroiliac joint (IIIa) and the bone destruction extended proximal to inferior border of the sacroiliac joint (IIIb). Six patients with IIIb lesions had significant prolonged surgical time (313.3 vs 249.0 min, P = 0.022), massive intraoperative hemorrhage (3533.3 vs 1760.0 mL, P = 0.093), poor functional outcome (46.7% vs 62.3%, P = 0.093), and unfavorable local control (31.3% vs 80.0%, P = 0.037) compared to the 10 patients with IIIa lesions. We then modified the surgical strategy for two subgroup of class III lesions: Harrington/modified Harrington procedure for IIIa lesions and en bloc resection followed by modular hemipelvic endoprosthesis replacement for IIIb lesions. Using the proposed modified surgical classification, 62 patients in the phase 2 study demonstrated improved surgical time (245.3 min, P = 0.086), intraoperative hemorrhage (1466.0 mL, P = 0.092), postoperative MSTS 93 scores (65.3%, P = 0.067), and 2‐year RFS rate (91.3%, P = 0.002) during a mean follow‐up time of 19.9 (1 to 60) months compared to those in the phase 1 study. CONCLUSION: The Harrington surgical classification is insufficient for class III lesions. We proposed modification of the classification for Harrington class III lesions by adding two subgroups and corresponding surgical strategies according to the involvement of bone destruction. Our proposed modified classification showed significant improvement in functional outcome and local control, along with acceptable surgical complexity in surgical management for Harrington class III lesions. John Wiley & Sons Australia, Ltd 2021-03-04 /pmc/articles/PMC7957435/ /pubmed/33665985 http://dx.doi.org/10.1111/os.12918 Text en © 2021 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Articles
Wei, Ran
Lim, Chiao Yee
Yang, Yi
Tang, Xiao‐dong
Yan, Tai‐qiang
Yang, Rong‐li
Guo, Wei
Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title_full Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title_fullStr Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title_full_unstemmed Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title_short Surgical Treatment and Proposed Modified Classification for Harrington Class III Periacetabular Metastases
title_sort surgical treatment and proposed modified classification for harrington class iii periacetabular metastases
topic Clinical Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957435/
https://www.ncbi.nlm.nih.gov/pubmed/33665985
http://dx.doi.org/10.1111/os.12918
work_keys_str_mv AT weiran surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT limchiaoyee surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT yangyi surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT tangxiaodong surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT yantaiqiang surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT yangrongli surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases
AT guowei surgicaltreatmentandproposedmodifiedclassificationforharringtonclassiiiperiacetabularmetastases